Alistair Milnes - Net Worth and Insider Trading
Alistair Milnes Net Worth
The estimated net worth of Alistair Milnes is at least $2 Million dollars as of 2024-11-05. Alistair Milnes is the CHIEF OPERATING OFFICER of Bicycle Therapeutics PLC and owns about 70,302 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $2 Million. Details can be seen in Alistair Milnes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alistair Milnes has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alistair Milnes
Alistair Milnes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alistair Milnes owns 2 companies in total, including Bicycle Therapeutics PLC (BCYC) , and Femasys Inc (FEMY) .
Click here to see the complete history of Alistair Milnes’s form 4 insider trades.
Insider Ownership Summary of Alistair Milnes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2024-10-03 | Chief Operating Officer |
| FEMY | Femasys Inc | 2023-06-14 | director |
Alistair Milnes Latest Holdings Summary
Alistair Milnes currently owns a total of 1 stock. Alistair Milnes owns 70,302 shares of Bicycle Therapeutics PLC (BCYC) as of October 3, 2024, with a value of $2 Million.
Latest Holdings of Alistair Milnes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2024-10-03 | 70,302 | 23.64 | 1,661,939 |
Holding Weightings of Alistair Milnes
Alistair Milnes Form 4 Trading Tracker
According to the SEC Form 4 filings, Alistair Milnes has made a total of 8 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Bicycle Therapeutics PLC is the sale of 972 shares on October 3, 2024, which brought Alistair Milnes around $21,637.
Insider Trading History of Alistair Milnes
- 1
Alistair Milnes Trading Performance
Alistair Milnes Ownership Network
Ownership Network List of Alistair Milnes
Ownership Network Relation of Alistair Milnes
Alistair Milnes Owned Company Details
What does Bicycle Therapeutics PLC do?
Who are the key executives at Bicycle Therapeutics PLC?
Alistair Milnes is the Chief Operating Officer of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and director & Chief Executive Officer Kevin Lee .
Bicycle Therapeutics PLC (BCYC) Insider Trades Summary
Over the past 18 months, Alistair Milnes made 6 insider transaction in Bicycle Therapeutics PLC (BCYC) with a net sale of 6,430. Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 21,235 shares made by Kevin Lee , a net sale of 6,430 shares made by Michael Skynner , and a net sale of 6,430 shares made by Nigel Crockett .
In summary, during the past 3 months, insiders sold 6,528 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 6,528 shares. During the past 18 months, 47,264 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,264 shares.
Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicycle Therapeutics PLC Insider Transactions
Alistair Milnes Mailing Address
Above is the net worth, insider trading, and ownership report for Alistair Milnes. You might contact Alistair Milnes via mailing address: C/o Bicycle Therapeutics Plc, B900, Babraham Research Campus, Cambridge X0 Cb22 3at.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
